Variants in 5 genes (RPN1, CDKN2A, HRAS, PALB2, CBFA2T3) have been identified in 32 individuals with tumor from the extended cohort and classified as pathogenic, likely pathogenic, and VUS (Supplementary Table 1). Here, PALB2 is linked to neoplasm.